BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SAPA-GP - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SAPA-GP
X-ORIGINAL-URL:https://sapagp.org
X-WR-CALDESC:Events for SAPA-GP
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200820T200000
DTEND;TZID=America/New_York:20200820T220000
DTSTAMP:20260425T121937
CREATED:20200730T120727Z
LAST-MODIFIED:20221201T193037Z
UID:2778-1597953600-1597960800@sapagp.org
SUMMARY:Arm yourself with legal and regulatory knowledge to navigate successfully in the new US-China business environment
DESCRIPTION:Register here\n\n\n\nArm yourself with legal and regulatory knowledge to navigate successfully in the new US-China business environment\n\n\n\n\n\n\nAbout this Event\n\n\nZoom meeting information will be sent to your email address after registration. \nSpeakers:\nJoshua Gruenspecht\, Partner at WSGR \nJennifer Fang\, Partner at WSGR \nZhipping (Louis) Liu\, Partner at Liu\, Chen Hoffman\, LLP \nYong Chen\, Partner at Liu\, Chen\, Hoffman\, LLP \n\nTopics by each speaker:\n1. Joshua Gruenspecht: \n· New CFIUS rules and implications for Chinese investments in the US in the life sciences industry\, as well as licensing into China\, and JV in China; \n· How CFIUS rules are being implemented as US-China relations continue to deteriorate\, and how to mitigate risks \n2. Jennifer Fang: \n· Trends in life sciences investments\, with a particular focus on milestone/tranched closings\, their pitfalls and considerations\, including pay to play\, voting issues\, and closing conditions. \n3. Louis Liu: \n· How to work with professional advisors while doing M&A or PE or JV deals with US counterparts; \n· How to conduct legal due diligence investigations of US counterparts; \n· How to integrate legal due diligence results\, commercial terms and legal terms into transaction documents with US counterparts; \n· The most common legal mistakes made by Chinese businesses doing deals or opening operations in the US. \n4. Yong Chen: \n· Fundamentals of Intellectual Property for Researchers and Entrepreneurs \n· Mitigation of Risks of Intellectual Property Violations in the New Era of Sino-US Relationship \nSpeaker Bio:\nJoshua Gruenspecht:Joshua Gruenspecht is a partner in the Washington\, D.C.\, office of Wilson Sonsini Goodrich & Rosati\, where he advises domestic and foreign investors\, funds\, established companies and startups in regulatory\, investigative\, and enforcement matters. He routinely represents parties before the Committee on Foreign Investment in the United States (CFIUS) and other government bodies on national security\, cybersecurity and communications matters. Gruenspecht has advised clients on CFIUS risk in hundreds of matters and is regularly invited to speak on CFIUS issues. \nJoshua has been recognized as an International Trade: CFIUS Expert by Chambers USA\, as one of the top 40 attorneys under the age of 40 in Washington\, DC by DCA Live\, and as a leading attorney in The Legal 500 U.S. in the areas of Telecom and Broadcast: Regulatory and Transactional. Joshua regularly helps U.S. companies and foreign investors in understanding and allocating CFIUS risk\, determining whether filings are required or advisable\, and navigating the CFIUS process. In addition\, he represents domestic businesses and foreign entities before the Defense Counterintelligence and Security Agency (DCSA)\, the Federal Communications Commission (FCC)\, federal defense and intelligence agencies\, state utilities commissions\, and other government bodies. \nPrior to joining Wilson Sonsini\, Joshua worked at a multinational law firm based in Washington\, D.C. He was previously a Cybersecurity Fellow with the Center for Democracy and Technology\, as well as an engineer working on network security research and development for the federal government and BBN Technologies\, focusing on device exploitation and computer network exploitation. Joshua has been quoted in prominent publications including The New York Times\, The Atlantic Monthly\, the Voice of America News\, and Law360. He holds a J.D. from Harvard Law School and a B.S. in Computer Science and English Literature from Yale University. \nJennifer Fang \nJennifer Fang is a corporate and securities partner in the Boston office of Wilson Sonsini Goodrich & Rosati. She helps innovative start-ups grow into successful enterprises by providing counsel to the founders\, management teams\, and boards and by handling the legal and strategic business issues and transactions that arise at each stage. She is experienced in negotiating and executing a variety of corporate transactions\, including conversions\, spinouts\, debt and equity financings\, public offerings\, PIPEs\, mergers and acquisitions\, and joint ventures. She also counsels venture capital\, growth capital\, and strategic investors with respect to their investment transactions and their existing portfolio companies. Her practice focuses on companies that can improve patient lives and healthcare through innovations and advances\, including in gene editing\, cell therapy\, novel therapeutics\, synthetic biology\, proteomics\, diagnostics\, bioinformatics\, medical devices\, and research and manufacturing tools and processes. \nShe is a frequent speaker on corporate and securities topics\, such as company formation risks\, equity compensation issues\, angel and venture financing terms\, and founder pitfalls\, and currently serves on the General Counsel Advisory Board of the National Venture Capital Association. In her free time\, she enjoys mentoring young lawyers\, entrepreneurs\, and investors in the local community. Ms. Fang received her J.D. from the University of Pennsylvania and a Master of Engineering in Biological Engineering and a Bachelor of Science in Biology from the Massachusetts Institute of Technology. \nZhiping Liu \nMr. Liu specializes in corporate law\, including corporate governance\, mergers and acquisitions\, commercial loans\, joint ventures and related areas. Mr. Liu has practiced in leading Wall Street and Silicon Valley law firms for more than seven years\, when he completed more than 100 large-scale transactions\, including mergers\, acquisitions\, investments\, and restructurings\, secured lending totaling more than $7 billion. Mr. Liu now leads the business practices of Liu\, Chen & Hoffman LLP\, a Chinese-American owned boutique business law firm that focuses on cross-border transactions\, intellectual property law and commercial dispute resolutions. Mr. Liu received his Juris Doctorate from New York University School of Law and is admitted to practice in New York and Georgia. \nYong Chen \nYong Chen is a founding partner of Liu\, Chen & Hoffman LLP. His practices focus on intellectual property law. Dr. Chen has counseled a range of clients including petrochemical\, chemical engineering\, pharmaceutical\, medical devices companies\, universities and research institutions in their patent and trademark portfolio management\, application drafting and prosecution\, invalidity/infringement investigation\, freedom-to-operate studies\, due diligence\, technology transfer and licensing\, and litigation. Dr. Chen earned his J.D. from New York University and his Ph.D. in Chemistry and M.S. in Computer Science from the Graduate Center of the City University of New York. He is admitted to practice in New York and before the US Patent and Trademark Office.
URL:https://sapagp.org/event/arm-with-legal-knowledge-to-navigate-in-new-us-china-business-environment/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/07/Screen-Shot-2020-08-01-at-10.00.54-e1596474290840.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200805T200000
DTEND;TZID=America/New_York:20200805T210000
DTSTAMP:20260425T121937
CREATED:20200614T210512Z
LAST-MODIFIED:20221201T193051Z
UID:2631-1596657600-1596661200@sapagp.org
SUMMARY:Career workshop: Accent reduction
DESCRIPTION:Career Workshop: Accent Reduction for Chinese Speakers: How to Speak with Clarity\, Cadence and Confidence \nSpeaker: Lauren Supraner\, President\, CAL Learning\, Accent Reduction and Intercultural Communication Expert; Author: Accent Reduction for Chinese Speakers; Leadership communication coach; Intercultural communication professional \nRegister HereSponsor
URL:https://sapagp.org/event/career-workshop-accent-reduction/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/06/Lauren-Supraner-e1592168688704.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200723T203000
DTEND;TZID=America/New_York:20200723T220000
DTSTAMP:20260425T121937
CREATED:20200621T003703Z
LAST-MODIFIED:20221201T193104Z
UID:2712-1595536200-1595541600@sapagp.org
SUMMARY:Buckle up for a bumpy ride – capital market update and exit strategy planning under the global pandemic
DESCRIPTION:Speakers \n\nRebecca Chan\, Partner\, Audit & Assurance\, Deloitte China\nLawrence Jin\, Partner\, Audit & Assurance\, Deloitte China\nDanny Wang\, Managing Director\, Audit & Assurance\, Deloitte & Touche LLP\nLili Zheng\, Partner\, International Tax\, Deloitte Tax LLP\n\n  \nAgenda  \n\nLegislative updates\nCapital market updates and exit strategy planning\n\n\nHK\, Mainland China\, US IPO trends & market comparison\nPanel Discussion – what you have seen from the market\n\n\nHow to recover and thrive in the current market situation\n\n\nCorporate structures and IP planning\nGlobal incentives for R&D\n\nRegister HereSpeakers:\nRebecca Chan \nNational Capital Market Leader\, China; Partner\, Audit & Assurance; Deloitte Touche Tohmatsu \nOffice: Hong Kong\, China \nRebecca has over 32 years of experience working with international accounting firms as well as the Hong Kong Exchanges and Clearing Limited where she headed the IPO Transactions Department and the Accounting Affairs Department of their Listing Division. She has been heavily involved in providing accounting and listing rules advice to clients and working on IPOs and post-listing transactions. Rebecca also provided regulatory rules suggestions to various overseas stock exchanges or markets. \nShe had also acted as a member of the Financial Reporting Advisory Panel of HKEx for the maximum term of six years. Rebecca is also a past member of the Dual Filing Advisory Group of the Securities & Futures Commission of Hong Kong responsible for advising on treatment of cases and policy issues under the dual filing regime for listing in Hong Kong. She is the only accountant by professional training in town who had acted as the Head of IPO Transactions Department in HKEx. \nLawrence Jin \nLife Sciences & Health Care (LSHC) National Audit leader\, China Eastern Region Market Leader; Partner\, Audit & Assurance; Deloitte China \nOffice: Shanghai\, China \nLawrence has over 24 years of auditing and advisory experience in both China and UK. He founded and currently leads LSHC audit practice in Deloitte China and has successfully led a number of high-profile IPOs in the sector in both China\, HK and the US capital markets. \nDanny Wang \nAudit Leader\, Deloitte US Chinese Services Group; Managing Director\, Audit & Assurance; Deloitte & Touche LLP \nOffice: New York\, USA \nDanny has over 18 years of experience in the financial services industry\, where he has led a number of audits of SEC registrants\, broker and dealers in securities and investment advisors. Danny’s focus is primarily on global audit coordination and execution\, SEC reporting and a variety of technical accounting topics. \nLili Zheng \nDeputy Managing Partner of US Chinese Services Group\, Asia Pacific Cross-Border Services Leader; Partner\, International Tax; Deloitte Tax LLP \nOffice: New York\, USA \nLili has more than 30 years of cross-border tax planning experience. She is responsible for Deloitte’s overall cross-functional services to MNCs investing Asia as well as Chinese & Asian clients investing in the US. Lili provides practical solutions to clients on their cross-border investment structuring\, IP planning\, JV planning\, M&A\, entry and exit strategies. \nSponsored by
URL:https://sapagp.org/event/buckle-up-for-a-bumpy-ride-capital-market-update-and-exit-strategy-planning-under-the-global-pandemic/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/06/July-23-webinar-revised-final-07152020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200709T200000
DTEND;TZID=America/New_York:20200709T210000
DTSTAMP:20260425T121937
CREATED:20200614T210104Z
LAST-MODIFIED:20221201T193118Z
UID:2627-1594324800-1594328400@sapagp.org
SUMMARY:Secret to success: building one meaningful relationship at a time
DESCRIPTION:Career workshop: Secret to success: building one meaningful relationship at a time \nSpeaker: Sara Gao\, program director\, Wharton executive education; instructor of global village for future leaders of business and industry program\, Lehigh University \nNo one can succeed alone. Ask anyone who achieved anything in life\, they will tell you somewhere along the way\, they were mentored\, encouraged\, inspired or lifted towards their success. From finding a potential customer to landing a dream job\, from partnering with a new colleague to leading an effective team\, relationship building is the secret to success. It is also a critical skill that we do not necessarily learn in school. In this interactive session\, we are going to explore some of the best practices in building meaningful relationships\, especially how we can pivot in our new reality. Come prepared with your audio and video on\, you will have an opportunity to practice live in virtual breakout rooms. \nSpeaker: Born in China\, educated in Europe\, Sara Gao has worked in Europe\, Asia\, and the USA as a talent development expert over the past 16 years. Sara currently works as program director at Wharton Executive Education. Her passion is to bring senior leaders from various industries around the world to a life changing learning experience\, so they are ready to create positive impacts for a better world. As a career coach\, Sara specializes on coaching Asian professionals to become successful leaders in a multicultural environment. \nRegister HereSponsored by\nView Recordings\nPart 1 \nSorry\, your browser doesn't support embedded videos.Part 2 \nSorry\, your browser doesn't support embedded videos.
URL:https://sapagp.org/event/secret-to-success-building-one-meaningful-relationship-at-a-time/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/06/Sara-Gao-e1592168390975.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200625T210000
DTEND;TZID=America/New_York:20200625T220000
DTSTAMP:20260425T121937
CREATED:20200614T203506Z
LAST-MODIFIED:20221201T193133Z
UID:2619-1593118800-1593122400@sapagp.org
SUMMARY:Creative Vaccine Development Strategies Amid the COVID-19 Outbreak
DESCRIPTION:Register HereCOVID-19 has wrought shutdowns and thousands of global deaths for almost six months. People are anxiously waiting for the chance to return to normal routines. Vaccines may bring that hope. Many companies have joined the race and began the development of COVID-19 vaccines. Some frontrunners have entered clinical trials. What are the differences between these vaccines? How to develop a vaccine in such a short time\, and what can we learn from this COVID-19 pandemic? Join us in this webinar. Dr. Li will answer these questions and share experiences on vaccine development strategies! \nSpeaker: Dr. Hangwen Li is the founder\, President and CEO of Stemirna Therapeutics. Dr. Li has over 20 years of experience in cancer research and treatment. His areas of interest include immunotherapy\, RNA therapeutics and cancer stem cells. Dr. Li’s published articles have been cited more than 2\,000 times. Dr. Li received his Ph.D. degree from the University of Texas M.D. Anderson Cancer Center.
URL:https://sapagp.org/event/creative-vaccine-development-strategies-amid-the-covid-19-outbreak/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2020/06/Screen-Shot-2020-06-13-at-22.16.47-1-e1592167853589.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200514T200000
DTEND;TZID=America/New_York:20200514T213000
DTSTAMP:20260425T121937
CREATED:20200504T001831Z
LAST-MODIFIED:20221201T193147Z
UID:2523-1589486400-1589491800@sapagp.org
SUMMARY:Learn from an expert:  Interviewing tips YOU need to know!
DESCRIPTION:What do you need to know about phone\, video\, and in-person interviews? What do you need to do to prepare for interviews? Learn from an expert: Interviewing tips YOU need to know! \nRegister HereSpeaker: \nDennis M. Gross\, M.S.\, Ph.D. \nDr. Gross has extensive experience in industry and academia. He received his Ph.D. in Cell Biology from the University of California\, Los Angeles. He did his postdoctoral training at Tulane University School of Medicine before joining the Merck Research Labs where he worked for 29 years retiring as Senior Director. He also serves as a Professor or Adjunct Professor at three universities and is the CEO of the Pennsylvania Drug Discovery Institute. In his talk\, he will offer some of the key things to be aware of when preparing for interviews. \nView Recordings \nSorry\, your browser doesn't support embedded videos.
URL:https://sapagp.org/event/learn-from-an-expert-interviewing-tips-you-need-to-know/
CATEGORIES:Career Events,Webex Meeting
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2020/05/online-video-call-interview-vector.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200424T120000
DTEND;TZID=America/New_York:20200424T130000
DTSTAMP:20260425T121937
CREATED:20200422T230153Z
LAST-MODIFIED:20221201T193204Z
UID:2511-1587729600-1587733200@sapagp.org
SUMMARY:COVID-19 Tax Relief under the CARES Act
DESCRIPTION:Speakers:\n1. Lili Zheng\, Partner\, Deloitte Tax LLP \n2. Priscilla Zhang\, Managing Director\, Deloitte Tax LLP \n3. Lynn Yang\, Managing Director\, Deloitte Tax LLP \nRegister Here
URL:https://sapagp.org/event/covid-19-tax-relief-under-the-cares-act/
CATEGORIES:Webex Meeting
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2020/04/unnamed-scaled-e1587581895120.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191214T043000
DTEND;TZID=America/New_York:20191214T120000
DTSTAMP:20260425T121937
CREATED:20191231T064841Z
LAST-MODIFIED:20221201T193247Z
UID:2139-1576297800-1576324800@sapagp.org
SUMMARY:2019 SAPA-GP Career Development Workshop
DESCRIPTION:Career Development Workshop \n\nGetting Your Next Promotion – What You Need to Know \n[/fusion_builder_row][/fusion_builder_container]Register Now[/fusion_code] \nHave you checked your career toolbox recently? Are you ready for your next promotion? Come build your knowledge in these areas and join us on December 14th\, 2019 at University of the Sciences – McNeil Technology Center (4308 Woodland Ave\, Philadelphia\, PA 19104) for a career development workshop held by the Sino-American Pharmaceutical Professionals Association – Greater Philadelphia (SAPA-GP). \nIn this one-day event focuses on Getting Your Next Promotion – What You Need to Know\, you will \n\nConstruct your career toolbox with the guidance of experts experienced in career development\, accent reduction\, and intercultural communication\nFind the right resources you will need in building up your skillset\nBe inspired by experiences shared by talents who were where you are standing and are now making their tremendous contributions to the pharmaceutical industry.\nExplore the emerging career opportunities with frontrunners from various fields of life sciences\n\nTentative Agenda: \n9:30-10:00     Registration\n10:00-10:15   Opening Remarks –Dr. David Cragin\n10:15-10:30    Introduction of SAPA-GP – Dr. Jing Yang\n10:30-11:10    Regulatory Sciences – Dr. Laurence Poli\n11:10-11:50    Building your toolbox- How to continue preparing yourself for the next job –Dr.Cynthia Cai\n11:50-13:20    Lunch\n13:20-14:10    Parallel Sessions I\nSession I-1: Facing Cross Roads: Making Effective Career Decisions – Dr. John Sun\, Ms. Sara Ying Gao\nSession I-2: Stones from Other Mountains: Advance Your Career with Skills from Consulting and Medical Communications- Dr. Yue Liu\, Dr. Steve Wu\nSession I-3: The Art of the interview: Do’s and Don’ts- Dr. Dennis Gross\n14:15-15:00    Parallel Sessions II\nSession II-1: Alternative career paths: Regulatory Affairs- Dr. Laurence Poli\, Ms. Shirley Ruan\nSession II-2: Polishing Your Speaking Skills for the Next Level- Ms. Lauren Supraner\nSession II-3: Tips for a successful mentorship- Ms. Hao Sun\n15:00-16:00    Networking \nFor sponsoring this\, kindly reach out to bd@sapa-gp.org and career@sapa-gp.org.
URL:https://sapagp.org/event/2019-sapa-gp-career-development-workshop/
LOCATION:University of Sciences-McNeil Technology Center\, 4308 Woodland Ave\, Philadelphia\, PA\, 19104\, United States
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2019/12/cdwagenda-short.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191207T080000
DTEND;TZID=America/New_York:20191207T150000
DTSTAMP:20260425T121937
CREATED:20201005T120037Z
LAST-MODIFIED:20221201T193309Z
UID:3231-1575705600-1575730800@sapagp.org
SUMMARY:Digital Revolution in BioPharma R&D and Beyond: Hype and Hope
DESCRIPTION:Digital Revolution in BioPharma R&D and Beyond: Hype and Hope Philadelphia Pharmaceutical Scientific Symposium 2019 \n\n\nAbout this Event\n\n\n2019 Philadelphia Pharmaceutical Scientific Symposium is titled “Digital Revolution in BioPharma R&D and Beyond: Hype and Hope”. \nJoin the vibrant Digital Technology in the BioPharma R&D community and exchange ideas with experts from academia and industry. Register Now! \n\n\n\n\nRegister HereAgenda \n8:00-8:30 Networking and Registration \n8:30-9:15 Computational Drug Design in the post-AI Era: Basic Principles and Case Studies – Dr. Guosheng Wu \n9:15-10:00 Artificial Intelligence and Machine Learning in the Pharmaceutical R&D – Dr. Andy Liaw \n10:00-10:15 Coffee Break \n10:15-11:00 The Impact of AI in Drug Discovery – Dr. Qingsong Zhu \n11:00-11:45 AI-Based Digital Pathology – Mr. Casey Laris \n12:00-13:00 Lunch \n13:00-13:45 Translational Human Data to Advance Drug Discovery-Challenges and Opportunities – Dr. Guna Rajagopal \n13:45-14:30 Digitally-Enabled Patient-Centric Clinical Trials: Current State and Future Opportunities – Dr. Matthew Moyer \n14:30-15:00 Networking and Close
URL:https://sapagp.org/event/digital-revolution-in-biopharma-rd-and-beyond-hype-and-hope/
LOCATION:Radnor Valley Country Club\, 555 Sproul Road\, Villanova\, PA
CATEGORIES:PPS
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2019/12/3-1-395x1024-1-e1601899222512.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191122T120000
DTEND;TZID=America/New_York:20191122T150000
DTSTAMP:20260425T121937
CREATED:20191228T203759Z
LAST-MODIFIED:20221201T193504Z
UID:2064-1574424000-1574434800@sapagp.org
SUMMARY:CAR-T: Transforming Blood Cancer Therapy
DESCRIPTION:CAR-T therapy development has achieved big success over the past years with regulatory approval by the FDA for blood cancer treatment. In this workshop\, experts from the industry will be assembled to discuss the development and implementation of this therapy. Their topics will cover several key aspects of the CAR-T industry chain\, from discovery\, manufacture to commercialization. \nRegister Now[/fusion_code] \nSpeaker 1: Allison Montalvo\, Executive Director\, Head of Project Management and Clinical Supply\, Tmunity Therapeutics\nTopic: CAR-T CMC management: how to streamline drug development\, manufacturing and logistics (Tentative)\nSpeaker 2: Fang Chen\, Senior Research Investigator\, Center for Cellular Immunotherapies (CCI)\, University of Pennsylvania\nTopic: Engineered T Cell Therapies From a Drug Development Viewpoint\nSpeaker 3: Teng Peng\, Application Support Manager\, ACROBiosystems\nTopic: The Applications of ACROBiosystem’s Products in CAR-T Cell Therapeutics\nSpeaker 4: Levi Gray-Rupp\, Associate Director\, CAR-T/iPSC\, Janssen\nTopic: Leveraging synthetic biology to enhance CAR-T safety and efficacy\n \nRegister Now[/fusion_code] \nSpeaker 1: Allison Montalvo\, Executive Director\, Head of Project Management and Clinical Supply\, Tmunity Therapeutics\nTopic: CAR-T CMC management: how to streamline drug development\, manufacturing and logistics (Tentative)\nSpeaker 2: Fang Chen\, Senior Research Investigator\, Center for Cellular Immunotherapies (CCI)\, University of Pennsylvania\nTopic: Engineered T Cell Therapies From a Drug Development Viewpoint\nSpeaker 3: Teng Peng\, Application Support Manager\, ACROBiosystems\nTopic: The Applications of ACROBiosystem’s Products in CAR-T Cell Therapeutics\nSpeaker 4: Levi Gray-Rupp\, Associate Director\, CAR-T/iPSC\, Janssen\nTopic: Leveraging synthetic biology to enhance CAR-T safety and efficacy\n \nRegister Now[/fusion_code] \nSpeaker 1: Allison Montalvo\, Executive Director\, Head of Project Management and Clinical Supply\, Tmunity Therapeutics\nTopic: CAR-T CMC management: how to streamline drug development\, manufacturing and logistics (Tentative)\nSpeaker 2: Fang Chen\, Senior Research Investigator\, Center for Cellular Immunotherapies (CCI)\, University of Pennsylvania\nTopic: Engineered T Cell Therapies From a Drug Development Viewpoint\nSpeaker 3: Teng Peng\, Application Support Manager\, ACROBiosystems\nTopic: The Applications of ACROBiosystem’s Products in CAR-T Cell Therapeutics\nSpeaker 4: Levi Gray-Rupp\, Associate Director\, CAR-T/iPSC\, Janssen\nTopic: Leveraging synthetic biology to enhance CAR-T safety and efficacy
URL:https://sapagp.org/event/car-t-transforming-blood-cancer-therapy/
LOCATION:University City Science Center\, 3675 Market St.\, Delaware River Room\, 3rd floor\, Philadelphia\, PA\, United States
CATEGORIES:AtPhilly
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2019/12/cart-1200x732-1.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190531T003000
DTEND;TZID=America/New_York:20190531T090000
DTSTAMP:20260425T121937
CREATED:20191229T213226Z
LAST-MODIFIED:20221201T193328Z
UID:2114-1559262600-1559293200@sapagp.org
SUMMARY:US-China Biopharma Congress 2019 & SAPA-GP 17th Annual Conference
DESCRIPTION:Innovate and Collaborate – Thriving in the Changing Dynamics of Global Life Sciences\n[/fusion_builder_row][/fusion_builder_container][/fusion_text]Register Now  \n [/fusion_builder_column_inner] Download Program [/fusion_builder_row_inner] \n  \n [Early bird registration ends Apr 21th]The clock is ticking! Register now to save! \nAs the flagship event of SAPA-GP\, our annual conference is expected to attract >1000 attendees\, including seasoned and young professionals from coast to coast\, several municipal government delegation teams from China\, over 20 CEOs or executives from most of the big pharma companies in China\, and high-level executives from major pharma companies such as GSK\, JNJ\, Merck\, BMS\, and Teva\, etc. \nAgenda5 Parallel Tracks: Science\, Technology\, Business\, Global Health\, and Career \nPlenary Session: Changing Dynamics of Global Life Sciences Confirmed speaker:  Felix Hsu\, SVP and Global Head of Advanced Therapies\, WuXi AppTecScience Track: Immunology Renaissance: The Yin and Yang of Immunomodulation and Therapeutic InnovationThe immune system is a double-edged sword\, requiring tightly regulated homeostasis. The morning session will showcase the benefits of stepping on the gas pedal of the immune system to fight against cancer and pathogens. Flipping the Yin&Yang immunology coin in the afternoon\, the overstimulated immune system could also lead to autoimmune\, inflammatory\, and neurogenerative diseases\, where a brake is a key to therapeutic success.  \nConfirmed speakers: Tong-Ming Fu\, Head of North America Vaccine Research\, Sanofi Pasteur Jan Joseph Melenhorst\, Director\, Product Development & Correlative Sciences Laboratory\, University of Pennsylvania Percy Carter\, Head of Discovery Chemistry & Molecular Technologies\, Drug Discovery Research\, BMS Eric Hostetler\, Executive Director\, Head of Translational Imaging Biomarkers\, Merck \nTechnology TrackThis session will cover cell and gene therapy\, expanding the horizon of small molecule discovery and emerging technology trend in biological developmentSmall molecule discovery: Although small molecule drugs are still the mainstream pharmaceuticals\, they are losing the competitiveness in certain disease areas to biologicals and other new modalities. This session will highlight some new horizons\, both scientifically and geographically\, in the hope to restore the glory of small molecules.Biological development: Biological drugs have seen remarkable increases in both utility and complexity in recent years\, for successful treatment of conditions including autoimmune disease and cancer. The session of Biologics will host seminars by key opinion leaders from major biopharma. Insights on scientific and strategic challenges and opportunities\, and market outlooks of the development of peptide\, protein\, RNA and antibody therapies will be shared.Confirmed speakers: Tauseef R. Butt\, President & CEO\, PROGENRA INC Linghang Zhuang\, Head of Chemistry\, Eternity Bioscience\, Inc \nBusiness Track: Unlocking the Potential for Innovation through Acquisitions\, Alliances and CollaborationCollaboration has never been more important in the biopharmaceutical industry than it is now.  Sourcing externally to strengthen R&D pipelines and bring much-needed new therapies to patients is pivotal for established biopharmaceutical companies.  “Deals” have also grown more complex and risky as disruptive scientific and technological advancements present both alluring opportunities and uncharted uncertainties. \nIn this track\, we have convened a panel of seasoned industry leaders and experts to discuss trends\, challenges\, and key success factors for big biopharmaceutical companies and small players to joint forces in accelerating innovation. The track will include three sessions: 1). the Evolving Landscape and Trends in Biopharma Collaborations; 2). Business Development & Licensing – Strategic Drivers for Making the Right Deals; 3). Alliance Management in Making a Collaboration Work. \nConfirmed speakers: Frederick (Rick) Jones\, Partner\, BioAdvance Jie (Jay) Liu\, Managing Director\, Torreya Partners \nGlobal Health TrackThis session will cover the forum\, Innovative Clinical Trials Design and Healthcare Advocacy. CEO forum is a well-planned\, exclusive gathering of more than ten well-known biotech leaders. They will share how they built their establishments\, discuss challenges in today’s dynamic industry environment both in China and the US and exchange their ideas about how to survive and thrive under the pressure and turbulence. The CEO forum is a highly interactive forum that you won’t want to miss. Innovative Clinical Trial Designs: To speed up new drug development and enhance the probability of success\, innovative trial designs have been increasingly adopted in clinical research. In this session\, we will discuss the design and application of adaptive\, umbrella\, and basket designs\, as well as other methodologies. Health advocacy session brings speakers from both public organizations and pharmaceutical companies to share the effort made towards the commitment of improving the lives of patients\, including better understanding patient needs\, disease awareness\, patient-focused public policies\, and patient diversity in clinical designs. \nConfirmed speakers: Xi-Yong (Sean) Fu\, President\, Luye Boston R&D LLC Li Chen\, President and CEO\, Hua Medicine Kevin Heyeck\, Venture Partner\, 6 Dimensions Capital Steve Abrams\, Partner\, Global Life Sciences Leadership Team\, Hogan Lovells Shell Li\, Chief Medical Officer and Chief Operating Officer\,  Hengruiyuan Larry Alphs\, Deputy Chief Medical Officer\, Newron Pharmaceuticals Parvin Fardipour\, Vice President\, Adaptive Clinical Trials\, ICON Plc. Chris Hansis\, Founder & CEO\, Phase Clinical Services (panelist) Anya Harry\, Clinical Trial Diversity Director\, GSK \nCareer Track: Diverse in Changing Career Pathways in Life Sciences. No matter which stage you are in your career\, there was always sometime you’ll have to stop\, look back\, think\, and look forward. This career session will open your eyes of personal growth and development\, and may inspire you to make important decisions towards career advancement.  \nBig pharma\, biotech companies and CMO/CROs will join the Job Fair with job openings for different levels\, bring your CV and name card\, your dream job will be landed here! \nOur guests: \n \n \n\n\nHigh-level executives from multi-national pharmaceutical companies and top Chinese pharmaceutical companies \n\n\nOfficials from local governments and municipal parties \n\n\nInventors from local universities and biotech companies \n\n\nElite scientists on pharmaceutical sciences \n\n\nDomain experts on intellectual property\, corporate finance\, and information technology \n\n\n \nWhy should you come? \n \n \n\n\nMeet high-level executives from pharmaceutical and biotech companies \n\n\nNetwork with investors and inventors \n\n\nFind recruiters or candidates \n\n\nReceive trainings on most up-to-date pharmaceutical sciences
URL:https://sapagp.org/event/us-china-biopharma-congress-2019-sapa-gp-17th-annual-conference/
LOCATION:Sheraton Valley Forge Hotel\, 480 North Gulph Road\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:AC
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2019/12/2019-AC-Flyer-V5-1-head.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
END:VCALENDAR